• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脆性 X 智力低下 1 号前突变和全突变与自闭症相关的分子机制。

FMR1 premutation and full mutation molecular mechanisms related to autism.

机构信息

Department of Pediatrics, University of California, Davis, School of Medicine, Sacramento, CA, USA,

出版信息

J Neurodev Disord. 2011 Sep;3(3):211-24. doi: 10.1007/s11689-011-9084-5. Epub 2011 May 27.

DOI:10.1007/s11689-011-9084-5
PMID:21617890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3261276/
Abstract

Fragile X syndrome (FXS) is caused by an expanded CGG repeat (>200 repeats) in the 5' un-translated portion of the fragile X mental retardation 1 gene (FMR1) leading to a deficiency or absence of the FMR1 protein (FMRP). FMRP is an RNA-binding protein that regulates the translation of a number of other genes that are important for synaptic development and plasticity. Furthermore, many of these genes, when mutated, have been linked to autism in the general population, which may explain the high comorbidity that exists between FXS and autism spectrum disorders (ASD). Additionally, premutation repeat expansions (55 to 200 CGG repeats) may also give rise to ASD through a different molecular mechanism that involves a direct toxic effect of FMR1 mRNA. It is believed that RNA toxicity underlies much of the premutation-related involvement, including developmental concerns like autism, as well as neurodegenerative issues with aging such as the fragile X-associated tremor ataxia syndrome (FXTAS). RNA toxicity can also lead to mitochondrial dysfunction, which is common in older premutation carriers both with and without FXTAS. Many of the problems with cellular dysregulation in both premutation and full mutation neurons also parallel the cellular abnormalities that have been documented in idiopathic autism. Research regarding dysregulation of neurotransmitter systems caused by the lack of FMRP in FXS, including metabotropic glutamate receptor 1/5 (mGluR1/5) pathway and GABA pathways, has led to new targeted treatments for FXS. Preliminary evidence suggests that these new targeted treatments will also be beneficial in non-fragile X forms of autism.

摘要

脆性 X 综合征(FXS)是由脆性 X 智力低下 1 基因(FMR1)5'非翻译区的 CGG 重复扩增(>200 个重复)引起的,导致 FMR1 蛋白(FMRP)缺失或缺乏。FMRP 是一种 RNA 结合蛋白,可调节其他一些对突触发育和可塑性很重要的基因的翻译。此外,这些基因中的许多在普通人群中与自闭症相关突变,这可能解释了 FXS 与自闭症谱系障碍(ASD)之间存在高共病的原因。此外,前突变重复扩增(55 至 200 个 CGG 重复)也可能通过涉及 FMR1 mRNA 直接毒性作用的不同分子机制引起 ASD。人们认为,RNA 毒性是前突变相关参与的基础,包括自闭症等发育问题,以及与衰老相关的神经退行性问题,如脆性 X 相关震颤共济失调综合征(FXTAS)。RNA 毒性也可导致线粒体功能障碍,在前突变携带者中,无论是否存在 FXTAS,这种情况都很常见。前突变和完全突变神经元中细胞调节紊乱的许多问题也与特发性自闭症中记录的细胞异常相平行。关于 FXS 中由于缺乏 FMRP 引起的神经递质系统失调的研究,包括代谢型谷氨酸受体 1/5(mGluR1/5)途径和 GABA 途径,导致了针对 FXS 的新靶向治疗方法。初步证据表明,这些新的靶向治疗方法也将对非脆性 X 形式的自闭症有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f004/3261276/e93fc86a0b7e/11689_2011_9084_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f004/3261276/e93fc86a0b7e/11689_2011_9084_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f004/3261276/e93fc86a0b7e/11689_2011_9084_Fig1_HTML.jpg

相似文献

1
FMR1 premutation and full mutation molecular mechanisms related to autism.脆性 X 智力低下 1 号前突变和全突变与自闭症相关的分子机制。
J Neurodev Disord. 2011 Sep;3(3):211-24. doi: 10.1007/s11689-011-9084-5. Epub 2011 May 27.
2
Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.脆性 X 综合征与自闭症:在分子水平上相互交织,为靶向治疗提供了依据。
Mol Autism. 2010 Sep 21;1(1):12. doi: 10.1186/2040-2392-1-12.
3
Fragile X: leading the way for targeted treatments in autism.脆性 X:自闭症靶向治疗的引领者。
Neurotherapeutics. 2010 Jul;7(3):264-74. doi: 10.1016/j.nurt.2010.05.005.
4
Fragile X syndrome and fragile X-associated tremor ataxia syndrome.脆性X综合征和脆性X相关震颤共济失调综合征。
Handb Clin Neurol. 2018;147:377-391. doi: 10.1016/B978-0-444-63233-3.00025-7.
5
Fragile X spectrum disorders.脆性X染色体谱系障碍
Intractable Rare Dis Res. 2014 Nov;3(4):134-46. doi: 10.5582/irdr.2014.01022.
6
Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.脆性 X 前突变小鼠中活动依赖性 FMRP 翻译受损和 mGluR 依赖性 LTD 增强。
Hum Mol Genet. 2013 Mar 15;22(6):1180-92. doi: 10.1093/hmg/dds525. Epub 2012 Dec 18.
7
[FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].[脆性X智力低下1号基因前突变携带者——他们真的没有症状吗?]
Harefuah. 2018 Apr;157(4):241-244.
8
High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome.患有脆性X综合征和脆性X相关震颤/共济失调综合征的高功能男性。
Am J Med Genet A. 2015 Sep;167A(9):2154-61. doi: 10.1002/ajmg.a.37125. Epub 2015 Apr 29.
9
Fragile X-Associated Neuropsychiatric Disorders (FXAND).脆性X染色体相关神经精神障碍(FXAND)
Front Psychiatry. 2018 Nov 13;9:564. doi: 10.3389/fpsyt.2018.00564. eCollection 2018.
10
Clinical, molecular, and pharmacological aspects of FMR1 related disorders.脆性X智力低下基因1相关疾病的临床、分子及药理学研究进展
Neurologia. 2017 May;32(4):241-252. doi: 10.1016/j.nrl.2014.10.009. Epub 2014 Dec 17.

引用本文的文献

1
Prosodic Differences in Women with the Premutation: Subtle Expression of Autism-Related Phenotypes Through Speech.具有前突变的女性的韵律差异:通过言语对自闭症相关表型的细微表达。
Int J Mol Sci. 2025 Mar 11;26(6):2481. doi: 10.3390/ijms26062481.
2
Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome.BKCa 通道 opener 氯唑沙宗在脆性 X 综合征小鼠模型中的治疗效果。
Neuropsychopharmacology. 2024 Dec;49(13):2032-2041. doi: 10.1038/s41386-024-01956-6. Epub 2024 Sep 2.
3
Autistic Traits Associated with the Fragile X Premutation Allele: The Neurodevelopmental Profile.

本文引用的文献

1
Diffusion tensor imaging in male premutation carriers of the fragile X mental retardation gene.脆性 X 智力低下基因男性前突变携带者的弥散张量成像。
Mov Disord. 2011 Jun;26(7):1329-36. doi: 10.1002/mds.23646. Epub 2011 Apr 11.
2
Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization.脆性 X 综合征中 DSM-IV 焦虑障碍的临床评估:患病率和特征。
J Neurodev Disord. 2011 Mar;3(1):57-67. doi: 10.1007/s11689-010-9067-y. Epub 2010 Dec 3.
3
Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models.
脆性 X 前突变等位基因与自闭症特质相关:神经发育特征。
Dev Neuropsychol. 2024 Jul;49(4):153-166. doi: 10.1080/87565641.2024.2351795. Epub 2024 May 16.
4
Behavioral and Psychiatric Disorders in Syndromic Autism.综合征性自闭症中的行为和精神障碍
Brain Sci. 2024 Mar 30;14(4):343. doi: 10.3390/brainsci14040343.
5
FMRP Enhances the Translation of mRNA during Neuronal Differentiation.FMRP 增强神经元分化过程中 mRNA 的翻译。
Int J Mol Sci. 2023 Nov 14;24(22):16319. doi: 10.3390/ijms242216319.
6
Large-Scale Whole Genome Sequence Analysis of >22,000 Subjects Provides no Evidence of Premutation Allele Involvement in Autism Spectrum Disorder.对超过 22000 名受试者的大规模全基因组序列分析未发现前突变等位基因参与自闭症谱系障碍。
Genes (Basel). 2023 Jul 25;14(8):1518. doi: 10.3390/genes14081518.
7
Diet in treatment of autism spectrum disorders.饮食在自闭症谱系障碍治疗中的应用
Front Neurosci. 2023 Jul 10;16:1031016. doi: 10.3389/fnins.2022.1031016. eCollection 2022.
8
Gene×environment interactions in autism spectrum disorders.自闭症谱系障碍中的基因-环境相互作用。
Curr Top Dev Biol. 2023;152:221-284. doi: 10.1016/bs.ctdb.2022.11.001. Epub 2022 Dec 19.
9
Presynaptic FMRP and local protein synthesis support structural and functional plasticity of glutamatergic axon terminals.突触前 FMRP 和局部蛋白质合成支持谷氨酸能轴突末梢的结构和功能可塑性。
Neuron. 2022 Aug 17;110(16):2588-2606.e6. doi: 10.1016/j.neuron.2022.05.024. Epub 2022 Jun 20.
10
Fragile X premutation carrier screening in Pakistani preconception women in primary care consultation.脆性 X 前突变携带者筛查在初级保健咨询中的巴基斯坦孕前女性。
BMC Womens Health. 2022 Mar 4;22(1):57. doi: 10.1186/s12905-022-01632-1.
遗传调控平衡神经发育障碍模型中的兴奋性和抑制性突触发生。
Front Synaptic Neurosci. 2010 Jun 7;2:4. doi: 10.3389/fnsyn.2010.00004. eCollection 2010.
4
A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome.基于体素的形态计量学研究脆性 X 相关震颤/共济失调综合征的灰质丢失。
Brain. 2011 Mar;134(Pt 3):863-78. doi: 10.1093/brain/awq368.
5
A mouse model of the fragile X premutation: effects on behavior, dendrite morphology, and regional rates of cerebral protein synthesis.脆性 X 前突变的小鼠模型:对行为、树突形态和大脑蛋白质合成区域率的影响。
Neurobiol Dis. 2011 Apr;42(1):85-98. doi: 10.1016/j.nbd.2011.01.008. Epub 2011 Jan 8.
6
Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.脆性 X 综合征中 FMR1 基因的表观遗传修饰与 mGluR5 拮抗剂 AFQ056 的不同反应相关。
Sci Transl Med. 2011 Jan 5;3(64):64ra1. doi: 10.1126/scitranslmed.3001708.
7
A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AI.米诺环素在 NGF 诱导的 PC12 细胞突起生长中的新作用靶点:翻译起始因子 eIF4AI[校正]。
PLoS One. 2010 Nov 8;5(11):e15430. doi: 10.1371/journal.pone.0015430.
8
Mitochondrial dysfunction in autism.自闭症中的线粒体功能障碍。
JAMA. 2010 Dec 1;304(21):2389-96. doi: 10.1001/jama.2010.1706.
9
Toward fulfilling the promise of molecular medicine in fragile X syndrome.致力于实现脆性 X 综合征分子医学的承诺。
Annu Rev Med. 2011;62:411-29. doi: 10.1146/annurev-med-061109-134644.
10
Seizures in fragile X syndrome: characteristics and comorbid diagnoses.脆性 X 综合征中的癫痫发作:特征和合并诊断。
Am J Intellect Dev Disabil. 2010 Nov;115(6):461-72. doi: 10.1352/1944-7558-115.6.461.